Categories: Updates

The International Journal of Cancer Care & Delivery Announces Article Awards

The International Journal of Cancer Care & Delivery, the Binaytara Foundation’s official medical journal, is inviting manuscripts from lung cancer experts and precision oncology experts for its 2021 article awards. A total of ten awards of $2,000 each are available and will be provided to the first author of the selected manuscripts.

The accepted manuscripts will be published in the open access journal and will provide continuing education credits to eligible healthcare providers upon meeting the required criteria for such credits. Expert physicians are invited to submit their abstracts under “Lung Cancer CME” category or “Precision Oncology CME” category.

The International Journal of Cancer Care & Delivery is an open access journal that doesn’t charge authors any fee to submit manuscripts. If you are interested in submitting manuscripts for the article awards or are interested in publishing your research, feel free to explore the information for authors.

Staff Writer - The Cancer News

Recent Posts

ADRIATIC: durvalumab (D) as consolidation treatment (tx) for patients (pts) with limited-stage small-cell lung cancer (LS-SCLC)

By: Tiantian Zhang1, Yiqun Han2, Lei Deng3 1. Department of Internal Medicine, University of Central…

5 months ago

ASCO24 LAURA Trial Summary

By: Zhiting Tang1, Lei Deng21. Unity Hospital, Rochester Regional Health, Rochester, NY2. University of Washington/Fred…

5 months ago

FDA Approves Tovorafenib for Pediatric Low-Grade Glioma With BRAF Mutation

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 23, 2024, the U.S. Food and Drug…

6 months ago

FDA Approves Tisotumab Vedotin for Recurrent or Metastatic Cervical Cancer

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 29, 2024, the U.S. Food and Drug…

6 months ago

FDA Approves Lutetium Lu 177 Dotatate for SSTR-Positive Gastroenteropancreatic Neuroendocrine Tumors

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 23, 2024, the U.S. Food and Drug…

6 months ago

FDA Approves Alectinib for Adjuvant Treatment in Non-Small Cell Lung Cancer

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 18, 2024, the U.S. Food and Drug…

6 months ago